The Discounted Cash Flow (DCF) valuation of Exagen Inc (XGN) is (17.01) USD. With the latest stock price at 3.04 USD, the upside of Exagen Inc based on DCF is -659.4%.
Based on the latest price of 3.04 USD and our DCF valuation, Exagen Inc (XGN) is a sell. selling XGN stocks now will result in a potential gain of 659.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 8.8% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (61.64) - (10.17) | (17.01) |
| Upside | -2127.8% - -434.5% | -659.4% |